orchard therapeutics stock price

ORTX a global gene therapy leader outlined five upcoming presentations from across its neurodegenerative portfolio to be featured at the 18th Annual WORLDSymposium being held on February 7-11 2022. On the other hand Orchard Therapeutics target price is what analysts think the stock is worth or could sell for in the future.

Orchard Therapeutics Plc Ortx Stock Price Us68570p1012 Marketscreener

Volume 172 million shs.

. Feb 2 54549 PM GMT-5 USD NASDAQ Disclaimer. Todays Range 106 117. Orchard Therapeutics PLC - ADR.

Orchard Therapeutics Pharming Ink Development Pact For Gene Therapy. The current price of Orchard Therapeutics is the price at which Orchard Therapeutics Plc is currently trading. View Orchard Therapeutics ORTX investment stock information.

Get Orchard Therapeutics PLC ORTXNASDAQ real-time stock quotes news price and financial information from CNBC. Orchard Therapeutics ORTX stock price charts trades the USs most popular discussion forums. Free forex prices toplists indices and lots more.

Get the latest Orchard Therapeutics ORTX detailed stock quotes stock data Real-Time ECN charts stats and more. As of Jan 21. The average twelve-month price target for Orchard Therapeutics is 1200 with a high price target of 1400 and a low price target of 900.

ORTX and Pharming Group NV NASDAQ. ORTX is 1325 last updated Today at 85550 PM. 102 rows Orchard Therapeutics plc ORTX Stock Historical Prices Data - Yahoo Finance.

Orchard Therapeutics Stock Forecast Price News 112 007 667 As of 0242022 0359 PM ET Todays Range 107 117 50-Day Range 088 151 52-Week Range 083 908 Volume 43831 shs Average Volume 720162 shs Market Capitalization 14056 million PE Ratio NA Dividend Yield NA Beta 112 Profile Analyst Ratings Chart. Orchard Therapeutics Stock Chart and Price History 113 008 762 As of 0242022 0400 PM ET Add. Orchard Therapeutics plc NASDAQ.

Average Volume 766394 shs. Free forex prices toplists indices and lots more. Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates.

Orchard Therapeutics current and average target prices are 105 and 1500 respectively. 52-Week Range 083 908. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic r Key Executives Trending Stocks TSLA Tesla Inc.

Today 52-Week Range. Ad 1000 Strong Buy Stocks that Double the SP. According to the issued ratings of 4 analysts in the last year the consensus rating for Orchard Therapeutics stock is Buy based on the current 1 sell rating and 3 buy ratings for ORTX.

Find the latest Orchard Therapeutics plc ORTX stock quote history news and other vital information to help you with your stock trading and investing. Stock analysis for Orchard Therapeutics plc ORTXNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. OTL-105 is an.

ET by Tomi Kilgore. The Investor Relations website contains information about Orchard Therapeuticss business for stockholders potential investors and financial analysts. Orchard Therapeutics plc ORTX Stock Price Today Quote News Seeking Alpha All Analysis News Transcripts SEC Filings Press Releases Related Analysis More.

PHAR have collaborated to research develop manufacture and commercialize OTL-105 for hereditary angioedema HAE. The stock price for. 2 days agoBOSTON and LONDON - Orchard Therapeutics Nasdaq.

Orchard Therapeutics started at outperform with 25 stock price target at Wedbush. Common Stock 9259599 -107601 115 AAPL Apple Inc. 50-Day Range 088 151.

26 2018 at 655 am. Orchard Therapeutics ORTX stock price charts trades the USs most popular discussion forums.

Orchard Therapeutics Assumed Overweight At Cantor With 9 Target Nasdaq Ortx Seeking Alpha